Search

everythinglearnresearchcommunity

for

Search:↓

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Eflornithine HCl 13.9% cream is safe for skin use with mild, temporary irritation.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Clascoterone is safe for the heart, even at high doses.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Macrofocused ultrasound is a safe and effective treatment for reducing enlarged facial pores.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Finasteride is not proven to cause depression or suicide, and careful patient monitoring is advised.

Topical finasteride may be safer than oral finasteride, but more research is needed.

Licensed hair gloss products improve shine and smoothness but require stricter regulation to ensure safety.

An AI device for skin cancer was successfully integrated into the NHS, improving diagnosis accuracy and service capacity.

Dermatologist visits offer safer and more ethical treatment for hair loss than direct-to-consumer platforms.

MpowerTM may improve hair growth and satisfaction more than plain minoxidil, with mild side effects.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Using minoxidil with microneedling increases hair count for hair loss without serious side effects.

The EVInews database provides significantly higher quality information than web-based sources for pharmacists.

New standards were created to make chemotherapy safer and improve cancer care.

Dutasteride is more effective than finasteride for hair loss but may affect male fertility and should be used cautiously.

Low-dose oral minoxidil is effective and safe for treating hair loss in men and women.

PRP therapy with Derma roller effectively promotes hair re-growth and reduces hair fall in women with pattern hair loss.

Once-daily 5% minoxidil foam increases hair regrowth and density in women with hair loss, but not as effectively as twice-daily 2% minoxidil solution, though it's safer and more convenient.

Generic drug inserts in Saudi Arabia often have inaccurate information, needing better regulation and quality control.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

SER120 nasal spray effectively reduces nighttime urination and is safe for patients.

The 1927-nm fractionated thulium laser treatment significantly improves hair thickness and count in pattern hair loss patients.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

A new model can predict drug-disease links well, helping drug research.